Loading asset research
Nasus Pharma Ltd. Ordinary Shares
NSRXNYSE · USD · StocksQuote as of · Exchange session not verified$3.40
+1.64%
Today
NSRX
Loading 1D prices…
Market cap
$39.9M
Volume
4.2K
52w high
$9.5052w low
$1.98Company profile
Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
TEL AVIV - YAFO, Israel, United States
Employees
7
Fiscal year end
1231
CIK
2029039
Session & valuation
Open$3.50
Previous close$3.35
Day high$3.50
Day low$3.40
30-day avg. volume13.5K
Outstanding shares9M
Diluted EPS-$0.72
Latest annual period
P/E (trailing)-4.73
P/E (forward)—
Price / book3.63
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| EDSAEdesa Biotech Inc. Common Shares | $40.8M | $0.00 | — | -$1.27 | -9.23% | Buy |
| IXHLIncannex Healthcare Inc. Common Stock | $39M | $86K | -19547.67% | -$1.51 | +0.31% | Hold |
| CELUCelularity Inc. Class A Common Stock | $40.8M | $26.6M | -345.45% | -$3.59 | -1.74% | Buy |
| CRVOCervoMed Inc. Common Stock | $38.9M | $4M | -673.15% | -$2.98 | +3.63% | Buy |
| VERUVeru Inc. Common Stock | $41.6M | $0.00 | — | -$1.55 | -2.40% | Buy |